Results 141 to 150 of about 1,074,043 (334)

Enhancement of BOLD-contrast sensitivity by single-shot multi-echo functional MR imaging [PDF]

open access: bronze, 1999
Stefan Posse   +9 more
openalex   +1 more source

EGFR‐STAT3 activation provides a therapeutic rationale for targeting aggressive ETV1‐positive prostate cancer

open access: yesMolecular Oncology, EarlyView.
Cotargeting EGFR and STAT3 with Erlotinib and TTI‐101 impairs both 2D and 3D growth of ETV1‐overexpressing prostate cancer cells by disrupting a self‐sustaining ETV1–EGFR positive feedback loop that promotes EGFR and STAT3 expression and phosphorylation (activation).
Elsa Gomes Paiva   +5 more
wiley   +1 more source

Enhanced tumor detection in the presence of liver cirrhosis: Experimental study on the diagnostic value of a superparamagnetic iron oxide MR imaging contrast agent (NSR 0430) [PDF]

open access: bronze, 1999
Rainald Bachmann   +5 more
openalex   +1 more source

Cytomegalovirus infection is common in prostate cancer and antiviral therapies inhibit progression in disease models

open access: yesMolecular Oncology, EarlyView.
Human cytomegalovirus infection is common in normal prostate epithelium, prostate tumor tissue, and prostate cancer cell lines. CMV promotes cell survival, proliferation, and androgen receptor signaling. Anti‐CMV pharmaceutical compounds in clinical use inhibited cell expansion in prostate cancer models in vitro and in vivo, motivating investigation ...
Johanna Classon   +13 more
wiley   +1 more source

Integrative miRNOMe profiling reveals the miR‐195‐5p–CHEK1 axis and its impact on luminal breast cancer outcomes

open access: yesMolecular Oncology, EarlyView.
In luminal (ER+) breast carcinoma (BC), miRNA profiling identified miR‐195‐5p as a key regulator of proliferation that targets CHEK1, CDC25A, and CCNE1. High CHEK1 expression correlates with worse relapse‐free survival after chemotherapy, especially in patients with luminal A subtype.
Veronika Boušková   +14 more
wiley   +1 more source

Chimeric diphtheria toxin–CCL8 cytotoxic peptide for breast cancer management

open access: yesMolecular Oncology, EarlyView.
DTCCL8 is a recombinant fusion toxin that targets cancer cells expressing chemokine receptors. By combining diphtheria toxin with CCL8, DTCCL8 binds to multiple receptors on tumor cells and induces selective cytotoxicity. This strategy enables receptor‐mediated targeting of cancer and may support the development of chemokine‐guided therapeutics ...
Bernardo Chavez   +5 more
wiley   +1 more source

Enhancing Brain MRI Super‐Resolution Through Multi‐Slice Aware Matching and Fusion

open access: yesCAAI Transactions on Intelligence Technology
In clinical diagnosis, magnetic resonance imaging (MRI) allows different contrast images to be obtained. High‐resolution (HR) MRI presents fine anatomical structures, which is important for improving the efficiency of expert diagnosis and realising smart
Jie Xiang   +7 more
doaj   +1 more source

Image Enhancement Method for Binarization of Drawings

open access: bronze, 1988
Naonori Ueda   +3 more
openalex   +2 more sources

Home - About - Disclaimer - Privacy